Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Pet Healthcare Product Market by Type (Vaccines, Paraciticides, Anti-infectives, Medicinal Feed Additives, Other), By Application (Dog, Cat, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Pet Healthcare Product Market by Type (Vaccines, Paraciticides, Anti-infectives, Medicinal Feed Additives, Other), By Application (Dog, Cat, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 150352 3300 Consumer Goods 377 240 Pages 4.9 (45)
                                          

Market Overview:


The global pet healthcare product market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The growth in the market can be attributed to the increasing trend of pet ownership, rising awareness about animal health, and growing demand for premium pet products. The market is segmented by type, application, and region. By type, the market is divided into vaccines, parasiticides, anti-infectives, medicinal feed additives and other products. Vaccines are expected to witness the highest growth during the forecast period owing to their preventive nature against various diseases in pets. By application, dog owners account for a majority of the share in terms of revenue followed by cat owners due to higher spending on healthcare products for these animals as compared with other pets such as birds or rabbits.


Global Pet Healthcare Product Industry Outlook


Product Definition:


A pet healthcare product is a type of medication or other item that is used to help keep pets healthy. These products can include things like flea and tick medication, heartworm prevention, and dietary supplements. The importance of using pet healthcare products cannot be overstated; without them, pets are at risk for a variety of illnesses and diseases.


Vaccines:


A vaccine is a procedure of introducing immunity-stimulating agents into the human body to stimulate the human immune system to produce antibodies, which helps protect against diseases. The most common vaccines are for measles, polio, and tetanus. Some vaccines are made to prevent infections that may be life-threatening; others may prevent mild or serious illnesses.


Paraciticides:


Paraciticides are used in the pet care industry to prevent parasitic infection in animals. They are also known as anti-parasitic drugs or antiparasitics. Paracitics can be administered orally, topically or by injection and their use is indicated for the treatment of various parasitic infections including hydatid disease (echinococcosis), cysticerosis (hydatide tumor), and ascariasis (intestinal roundworm infection).


Application Insights:


The dog application segment led the global pet healthcare product market in 2017. The growing trend of owning a pet and increasing disposable income are the major factors driving this segment. Moreover, rising awareness about preventive healthcare is also expected to have a positive impact on this market over the forecast period.


Pet owners usually spend around USD 15 on average for each month of their pets¢â‚¬â„¢ life, which amounts to more than USD 150 annually for a medium-sized dog and approximately USD 210 annually for large dogs. This amount increases with age as well as depends upon various other factors such as hereditary diseases that may require medical treatment or vaccines that need to be administered along with it.


Regional Analysis:


North America dominated the global pet healthcare product market in 2017. This can be attributed to increasing awareness about animal health, high purchasing power of consumers, and availability of advanced veterinary services. Moreover, rising incidence of chronic diseases in pets is expected to drive demand for medicines and vaccines over the forecast period.


Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rapid urbanization along with growing economy & population in this region has led towards an increase in disposable income which will eventually lead towards a rise in pet adoption rates thereby driving demand for various pet healthcare products such as medicines, diagnostics services among others.


Growth Factors:


  • Increasing pet ownership
  • Rising awareness about preventive healthcare for pets
  • Growing demand for premium and customized pet products
  • Proliferation of online retail platforms catering to pet owners
  • Increased focus on research and development by pet product manufacturers

Scope Of The Report

Report Attributes

Report Details

Report Title

Pet Healthcare Product Market Research Report

By Type

Vaccines, Paraciticides, Anti-infectives, Medicinal Feed Additives, Other

By Application

Dog, Cat, Other

By Companies

Pfizer, Merck, Sanofi-Aventis, Bayer HealthCare, Virbac, Novartis, Boehringer Ingelheim, Heska Corporation, Bioniche Animal Health Canada, Inc., Ceva, Johnson & Johnson, MedFly, Zoetis, 3M, R. M. Hatcheries, Lomir Biomedical

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

240

Number of Tables & Figures

168

Customization Available

Yes, the report can be customized as per your need.


Global Pet Healthcare Product Market Report Segments:

The global Pet Healthcare Product market is segmented on the basis of:

Types

Vaccines, Paraciticides, Anti-infectives, Medicinal Feed Additives, Other

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Dog, Cat, Other

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Pfizer
  2. Merck
  3. Sanofi-Aventis
  4. Bayer HealthCare
  5. Virbac
  6. Novartis
  7. Boehringer Ingelheim
  8. Heska Corporation
  9. Bioniche Animal Health Canada, Inc.
  10. Ceva
  11. Johnson & Johnson
  12. MedFly
  13. Zoetis
  14. 3M
  15. R. M. Hatcheries
  16. Lomir Biomedical

Global Pet Healthcare Product Market Overview


Highlights of The Pet Healthcare Product Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Vaccines
    2. Paraciticides
    3. Anti-infectives
    4. Medicinal Feed Additives
    5. Other
  1. By Application:

    1. Dog
    2. Cat
    3. Other
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Pet Healthcare Product Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Pet Healthcare Product Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


A pet healthcare product is a type of product that is designed to help keep your pet healthy. These products can include things like food, toys, treats, and medicines.

Some of the major players in the pet healthcare product market are Pfizer, Merck, Sanofi-Aventis, Bayer HealthCare, Virbac, Novartis, Boehringer Ingelheim, Heska Corporation, Bioniche Animal Health Canada, Inc., Ceva, Johnson & Johnson, MedFly, Zoetis, 3M, R. M. Hatcheries, Lomir Biomedical.

The pet healthcare product market is expected to register a CAGR of 6.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Pet Healthcare Product Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Pet Healthcare Product Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Pet Healthcare Product Market - Supply Chain
   4.5. Global Pet Healthcare Product Market Forecast
      4.5.1. Pet Healthcare Product Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Pet Healthcare Product Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Pet Healthcare Product Market Absolute $ Opportunity

5. Global Pet Healthcare Product Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Pet Healthcare Product Market Size and Volume Forecast by Type
      5.3.1. Vaccines
      5.3.2. Paraciticides
      5.3.3. Anti-infectives
      5.3.4. Medicinal Feed Additives
      5.3.5. Other
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Pet Healthcare Product Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Pet Healthcare Product Market Size and Volume Forecast by Application
      6.3.1. Dog
      6.3.2. Cat
      6.3.3. Other
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Pet Healthcare Product Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Pet Healthcare Product Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Pet Healthcare Product Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Pet Healthcare Product Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Pet Healthcare Product Demand Share Forecast, 2019-2026

9. North America Pet Healthcare Product Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Pet Healthcare Product Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Pet Healthcare Product Market Size and Volume Forecast by Application
      9.4.1. Dog
      9.4.2. Cat
      9.4.3. Other
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Pet Healthcare Product Market Size and Volume Forecast by Type
      9.7.1. Vaccines
      9.7.2. Paraciticides
      9.7.3. Anti-infectives
      9.7.4. Medicinal Feed Additives
      9.7.5. Other
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Pet Healthcare Product Demand Share Forecast, 2019-2026

10. Latin America Pet Healthcare Product Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Pet Healthcare Product Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Pet Healthcare Product Market Size and Volume Forecast by Application
      10.4.1. Dog
      10.4.2. Cat
      10.4.3. Other
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Pet Healthcare Product Market Size and Volume Forecast by Type
      10.7.1. Vaccines
      10.7.2. Paraciticides
      10.7.3. Anti-infectives
      10.7.4. Medicinal Feed Additives
      10.7.5. Other
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Pet Healthcare Product Demand Share Forecast, 2019-2026

11. Europe Pet Healthcare Product Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Pet Healthcare Product Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Pet Healthcare Product Market Size and Volume Forecast by Application
      11.4.1. Dog
      11.4.2. Cat
      11.4.3. Other
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Pet Healthcare Product Market Size and Volume Forecast by Type
      11.7.1. Vaccines
      11.7.2. Paraciticides
      11.7.3. Anti-infectives
      11.7.4. Medicinal Feed Additives
      11.7.5. Other
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Pet Healthcare Product Demand Share, 2019-2026

12. Asia Pacific Pet Healthcare Product Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Pet Healthcare Product Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Pet Healthcare Product Market Size and Volume Forecast by Application
      12.4.1. Dog
      12.4.2. Cat
      12.4.3. Other
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Pet Healthcare Product Market Size and Volume Forecast by Type
      12.7.1. Vaccines
      12.7.2. Paraciticides
      12.7.3. Anti-infectives
      12.7.4. Medicinal Feed Additives
      12.7.5. Other
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Pet Healthcare Product Demand Share, 2019-2026

13. Middle East & Africa Pet Healthcare Product Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Pet Healthcare Product Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Pet Healthcare Product Market Size and Volume Forecast by Application
      13.4.1. Dog
      13.4.2. Cat
      13.4.3. Other
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Pet Healthcare Product Market Size and Volume Forecast by Type
      13.7.1. Vaccines
      13.7.2. Paraciticides
      13.7.3. Anti-infectives
      13.7.4. Medicinal Feed Additives
      13.7.5. Other
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Pet Healthcare Product Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Pet Healthcare Product Market: Market Share Analysis
   14.2. Pet Healthcare Product Distributors and Customers
   14.3. Pet Healthcare Product Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Pfizer
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Merck
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Sanofi-Aventis
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Bayer HealthCare
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Virbac
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Novartis
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Boehringer Ingelheim
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Heska Corporation
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Bioniche Animal Health Canada, Inc.
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Ceva
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. Johnson & Johnson
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. MedFly
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. Zoetis
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. 3M
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. R. M. Hatcheries
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. Lomir Biomedical
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us